AB 170 aims to transform the state’s newborn blood testing program from an “opt out” to an “opt in” program, reduced the number of newborns being tested for genetic diseases and imposed new conditions on the use and storage of blood samples for medical research.
AB 374 requires insurers to expeditiously grant a patient’s step therapy override determination request when accompanied by supporting rationale and documentation from the prescribing physician.
Among other things, AB 339 requires that copayments, coinsurance and other cost sharing for outpatient prescription drugs be “reasonable” and prohibits an insurer from placing most or all of the drugs to treat a single condition on the highest tier of a formulary unless there is a therapeutic equivalent drug available in a lower cost tier.
CHI’s State Legislative Committee (SLC) Reviews Legislation for 2015 On March 9, CHI members met to analyze the immense number of bills introduced for this legislative year. After sifting through hundreds of bills, CHI is currently tracking 64 bills that directly impact the life sciences industry and its member companies/institutions. As we continue to watch … Continue reading Sacramento at a Glance — March 20, 2015 — CHI’s State Legislative Committee (SLC) Reviews Legislation for 2015
Deadline to Introduce Bills in Sacramento Feb. 27 was the deadline for state lawmakers to introduce the bills they will consider for the current legislative year. From now until Sept. 11, 2015, legislators have the time to send these measures to the Governor for a signature or veto. For the past several weeks and throughout … Continue reading Sacramento at a Glance — March 6, 2015 — Deadline to Introduce Bills in State Legislature; Merger Update
Monthly Speaker Series with Assembly Appropriations Committee Chair Jimmy Gomez At our February Monthly Speaker Series, Assembly Appropriations Committee Chair Jimmy Gomez engaged with a room full of CHI members about the rising cost of healthcare and the Appropriations Committee’s effects on public policy. Assemblymember Gomez recognizes the importance of the life sciences industry to … Continue reading Sacramento at a Glance — Feb. 23, 2015 — CHI Hosts Asm. Jimmy Gomez, Chair of the Appropriations Committee
Over 60 Legislators attend CHI’s Back to Session Reception On Jan. 21, CHI celebrated the value of innovation with state public policy and industry leaders in California’s life sciences sector. More than 60 legislators from both the Senate and the Assembly, legislative staff, biomedical industry executives, academic leaders and the patient community attended the Back … Continue reading Sacramento at a Glance — Over 60 Legislators attend CHI’s Back to Session Reception
2014 has been an important year for California’s life sciences industry. Issues that directly impact our industry, such as healthcare reform, patient access, taxes and the environment have all been front and center. 2015 will present many of these same challenges, and many new ones. It is critical for us to identify and recognize those … Continue reading Sacramento at a Glance — California Legislature Reconvenes